<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: Early data from a significant UK series of HIFU patients</title>
	<atom:link href="http://prostatecancerinfolink.net/2009/07/02/early-data-from-a-significant-uk-series-of-hifu-patients/feed/" rel="self" type="application/rss+xml" />
	<link>http://prostatecancerinfolink.net/2009/07/02/early-data-from-a-significant-uk-series-of-hifu-patients/</link>
	<description></description>
	<lastBuildDate>Tue, 14 Feb 2012 02:28:48 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: Sitemaster</title>
		<link>http://prostatecancerinfolink.net/2009/07/02/early-data-from-a-significant-uk-series-of-hifu-patients/#comment-5485</link>
		<dc:creator><![CDATA[Sitemaster]]></dc:creator>
		<pubDate>Thu, 30 Jul 2009 19:36:03 +0000</pubDate>
		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=6254#comment-5485</guid>
		<description><![CDATA[Ron:

It&#039;s called a conflict of interests, and it is perfectly normal to exclude from major randomized clinical trials of this type any physician who has a demonstrable business interest in the outcome.

Also, if you look at the top of this page, you will see a referral to the fact that this is an outdated report and gives a link to a later report that includes the exact quotation from Emberton that you mention.]]></description>
		<content:encoded><![CDATA[<p>Ron:</p>
<p>It&#8217;s called a conflict of interests, and it is perfectly normal to exclude from major randomized clinical trials of this type any physician who has a demonstrable business interest in the outcome.</p>
<p>Also, if you look at the top of this page, you will see a referral to the fact that this is an outdated report and gives a link to a later report that includes the exact quotation from Emberton that you mention.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: ron</title>
		<link>http://prostatecancerinfolink.net/2009/07/02/early-data-from-a-significant-uk-series-of-hifu-patients/#comment-5484</link>
		<dc:creator><![CDATA[ron]]></dc:creator>
		<pubDate>Thu, 30 Jul 2009 19:01:34 +0000</pubDate>
		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=6254#comment-5484</guid>
		<description><![CDATA[In the latest UK trial, the head doctor, Mark Emberton, wrote, &quot;Most of the [occurrences of retained debris or stricture] were clustered to the early part of the series at the beginning of our learning curve” and “If rates similar to those reported in this paper had persisted we would not have wanted to continue with this treatment.” 

Yes, &quot;learning curve&quot;....can you imagine the stellar outcome if the doctors in the trials had actually been experienced?  

Even in America they would not let our most experienced doctors into the clinical trials.  They told Dr. Scionti (my HIFU doc) that they were afraid he would have a bias toward the trials being successful, so he wasn&#039;t allowed in.]]></description>
		<content:encoded><![CDATA[<p>In the latest UK trial, the head doctor, Mark Emberton, wrote, &#8220;Most of the [occurrences of retained debris or stricture] were clustered to the early part of the series at the beginning of our learning curve” and “If rates similar to those reported in this paper had persisted we would not have wanted to continue with this treatment.” </p>
<p>Yes, &#8220;learning curve&#8221;&#8230;.can you imagine the stellar outcome if the doctors in the trials had actually been experienced?  </p>
<p>Even in America they would not let our most experienced doctors into the clinical trials.  They told Dr. Scionti (my HIFU doc) that they were afraid he would have a bias toward the trials being successful, so he wasn&#8217;t allowed in.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

